Last reviewed · How we verify
NCT06264050: SUPPORT
Psychological Support Group and Its Effects on Mood, Anxiety and Coping
NA trial testing evalutaion scales in Coping Strategies in 19 participants. Status unknown.
8 September 2024
Quick facts
| Lead sponsor | IRCCS San Camillo, Venezia, Italy |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 19 |
| Start date | 8 January 2004 |
| Primary completion | 8 September 2024 |
| Estimated completion | 15 March 2025 |
Drugs / interventions tested
- evalutaion scales
Conditions studied
- Coping Strategies — all drugs for Coping Strategies →
- Anxiety — all drugs for Anxiety →
- Nurse-Patient Relations — all drugs for Nurse-Patient Relations →
- Psychological — all drugs for Psychological →
Sponsor
IRCCS San Camillo, Venezia, Italy
Who can join
Adults 18 to 85, any sex, with Coping Strategies or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to verify the influence that participation in a Psychological Support Group has on anxiety, depression and coping skills in patients admitted to the IRCCS San Camillo Hospital. It is therefore an observational study with a pre-post design on a cohort of patients hospitalized at San Camillo IRCCS who attend the Psychological Support Group. The study consists of verifying whether the therapeutic activity of the Psychological Support Group (GSP) has an influence on the levels of anxiety, mood and coping skills in the patients who attend it. These purposes will be pursued through the administration to each patient at the beginning (pre) and at the end (post) of the period of attendance at the GSP, of validated scales: Stay Y2 (anxiety), BDI II(depressive symptoms), COPE NVD 25 (coping strategies) and the CORE-OM (outcomes of psychological activity).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06264050
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other IRCCS San Camillo, Venezia, Italy trials
Trials by the same sponsor.
- NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
- NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
- NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
- NCT06270420 — Technological Devices and Home Automation System in Neurological Rehabilitation · NA · unknown
- NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06264050 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
- Last refreshed: 16 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06264050.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing